Editor's Picks Back « 1 2 3 4 5
6 7 8 9 10 ... » Next- H.I.V. Diagnosis Rates Continue to Rise Among Young Men, African-Americans
The New York Times - One in 10 had "silent strokes": study
Reuters - Insured losing access to healthcare: U.S. study
Reuters - Tensions grow over cancer treatments
Financial Times - City Is Pushing for H.I.V. Tests for All in Bronx
The New York Times - Scientists identify possible Alzheimer's gene
Associated Press - Novel treatments ease migraine pain
HealthDay News - Repairing damage to brain may be nearer
San Diego Union Tribune - Gene testing questioned by regulators
The New York Times - Cervical cancer vaccine not cleared for older women
Baltimore Sun - Merck Diabetes Pill Januvia Set to Rejuvenate Shares
Reuters - Morbid thoughts make you reach for cookies
Reuters - Genome testing firms in California defy state order to stop
San Francisco Chronicle - House votes to block cut in doctors' Medicare fees
The New York Times - Parasitic diseases plague poor in urban areas, specialist says
Reuters - Drug-coated stents reduce repeat artery procedures
HealthDay News - House subcommittee ok's $2.1B in FDA funding
HealthImagingNews - Protein may be key to colon cancer vaccine
Reuters - Doctors say medication is overused in dementia
The New York Times - U.K. to inform patients about clinical trials
Financial Times - Pfizer eyes stem cells for treating retina damage
Forbes.com - DNA testing company stops direct-to-consumer sales in California
Wired News - Drug-resistant high blood pressure on the rise
The New York Times - FDA says medical device reviews became faster
Reuters - Researchers discover new clue to the cause of Alzheimer's
Associated Press - Hip resurfacing gains popularity but there are risks
Boston Globe - China presses injured athletes in quest for gold
New York Times - European drug industry reconsiders its strategy
Reuters - U.S. researchers discover new source of heart stem cells
Agence France Presse - British biotech execs say U.K. industry is in a rut
Financial Times - U.S. FDA seeks India post for food, drug checks
Reuters - Senator Wants FDA Probe of India, China Pharma
BusinessWeek - Investigation of Glaxo's Paxil widens: paper
Reuters - Lawmakers Approve Detailed Map of State's Cancer Cases
The New York Times - Settlement to Ease Drug Costs for Some on Medicare
The New York Times - "Virtual man" may ease drug R&D woes: report
Reuters - Americans lacking in health literacy
Reuters - Most Doctors Aren't Using Electronic Health Records
The New York Times - FDA Panel Recommends Enbrel for Pediatric Patients
HealthDay News - States push biotech progress to bolster U.S. economy
The Arizona Republic - Medicare spells out rights of hospice patients
Reuters - FDA hopes to open China offices by year end
Reuters - Wyeth Shares Rise on Promising Study of Alzheimer's Drug
The New York Times - Drug price deal to cut company profits
Financial Times - Study finds depression can trigger diabetes
Reuters - Cholesterol genes 'protect heart'
BBC - Calif. cracks down on 13 genetic testing startups
The Associated Press - Biotech business sees growth in global woes
The Denver Post - Massachusetts to spend $1 billion on biotechnology
Reuters - Md. joins sprint to lead in biotechnology
The Baltimore Sun - Eyes Bloodshot, Doctors Vent Their Discontent
The New York Times - Kleiner Perkins makes bet on adult stem cells
The San Francisco Chronicle - BIO chief talks about industry's concerns
San Diego Union-Tribune - Risk-averse investors threaten drug development
The Independent - Bernanke: Rising Health Costs a Strain
The Associated Press - Index Ranks Pharmaceutical Groups According to Third World Outreach
The New York Times - Japan, Seeking Trim Waists, Measures Millions
The New York Times - Rheumatoid arthritis said to double heart risk
Reuters - Pfizer May Vie With Daiichi for Ranbaxy, Paper Says
Bloomberg - Billion-dollar life sciences bill passes Senate; governor to sign Monday
The Boston Globe - U.S. Life Expectancy Reaches Record
The Associated Press - Gay Unions Shed Light on Gender in Marriage
The New York Times - Big Pharma's R&D Booster Shot
BusinessWeek - Allergies cost Americans $11 billion: survey
Reuters - Promising drug fights Alzheimer's in three ways
Reuters - U.S. biofuels industry presses for tax breaks
Reuters - Needle-free vaccine may stop Montezuma's Revenge
Reuters - Pols push $1 billion biotech bill
The Boston Herald - In Europe, Debate Over Islam and Virginity
The New York Times - Death risk charts put smoking harm in perspective
Reuters - Better counting raises HIV rate in U.S. by 25 percent
Reuters - Biogen says proxy advisers back it in Icahn fight
Reuters - Ranks of Underinsured Are Rising, Study Finds
The New York Times - Wall Street scrutinizes Medicare payment proposal
The Associated Press - UCSF, Pfizer sign collaborative research deal
The San Francisco Chronicle - GSK to shake-up research strategies
Financial Times - Smoking hurts mind as well as body: study
Reuters - Spread of Tuberculosis Seen Slowing Progress on AIDS
The New York Times - Facing Life Without Children When It Isn't by Choice
The New York Times - New approach promising against multiple sclerosis
Reuters - Kaiser Backs Microsoft Patient-Data Plan
The New York Times - Researchers Fail to Reveal Full Drug Pay
The New York Times - Concerned About Costs, Congress Pushes Curbs on Doctor-Owned Hospitals
The New York Times - Guideline would boost cholesterol drug use
Reuters - EU agency sees more drug cost-effective disputes
Reuters - FDA, Facing Criticism, Bars Doctors From Drug Trials
Bloomberg - Ipsen seeks U.S. growth with $404 mln Tercica deal
Reuters - FDA panel to discuss Roche arthritis drug July 29
Reuters - Wal-Mart's Detractors Come In From the Cold
The New York Times - Indonesia changes policy on reporting bird flu deaths
Reuters - A City Where Hospitals Are as Ill as the Patients
The New York Times - Opposition to Menthol Cigarettes Grows
The New York Times - Mercury teeth fillings may harm some: FDA
Reuters - Research Finds Wide Disparities in Health Care by Race and Region
The New York Times - Drug companies drain scientific brains from FDA
The Associated Press - U.S. probes cancer in children given arthritis drugs
Reuters - Gilead, Boehringer Freeze Prices on AIDS Drugs to U.S. Agencies
Bloomberg - New melanoma drugs - why do so few benefit?
Reuters - Drug-resistant bug kills young and healthy in U.S.
Reuters - New weapon against malaria identified
Reuters
Back « 1 2 3 4 5
6 7 8 9 10 ... » Next
